TAVR-in-TAVR procedure on a patient with cardiogenic shock due to a degenerated corevalve

Jose Airton De Arruda, Alfredo Nunes Ferreira Neto, Bruno Moulin Machado, Vitor Arantes Pazolini, Rodolpho de Mello Farinazzo, Rafael Rua Figueiredo, Melchior Luiz Lima, Fabio Sandoli De Brito Jr

While Transcatheter Aortic Valve Replacement (TAVR) has expanded accept changas a treatment for symptomatic aortic valve stenosis, little is known about its long-term outcomes. We present a 92-years-old female presenting with cardiogenic shock due to an 8-years-old degenerated transcatheter heart valve submitted to life-saving balloon valvuloplasty and redo TAVR.